Josep M Llovet
Josep M Llovet
Prof. of Medicine - Director M Sinai Liver Cancer Prog/ Prof of Research ICREA, BCLC group
Email verificata su clinic.cat - Home page
Titolo
Citata da
Citata da
Anno
Sorafenib in advanced hepatocellular carcinoma
JM Llovet, S Ricci, V Mazzaferro, P Hilgard, E Gane, JF Blanc, ...
New England journal of medicine 359 (4), 378-390, 2008
105042008
Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference
J Bruix, M Sherman, JM Llovet, M Beaugrand, R Lencioni, AK Burroughs, ...
Journal of hepatology 35 (3), 421-430, 2001
46242001
Prognosis of hepatocellular carcinoma: the BCLC staging classification
JM Llovet, C Br, J Bruix
Seminars in liver disease 19 (03), 329-338, 1999
32381999
Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival
JM Llovet, J Bruix
Hepatology 37 (2), 429-442, 2003
31652003
Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial
JM Llovet, MI Real, X Montaa, R Planas, S Coll, J Aponte, C Ayuso, ...
The Lancet 359 (9319), 1734-1739, 2002
31652002
Modified RECIST (mRECIST) assessment for hepatocellular carcinoma
R Lencioni, JM Llovet
Seminars in liver disease 30 (01), 052-060, 2010
25692010
Intention‐to‐treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation
JM Llovet, J Fuster, J Bruix
Hepatology 30 (6), 1434-1440, 1999
18391999
Design and endpoints of clinical trials in hepatocellular carcinoma
JM Llovet, AM Di Bisceglie, J Bruix, BS Kramer, R Lencioni, AX Zhu, ...
Journal of the National Cancer Institute 100 (10), 698-711, 2008
17542008
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
J Bruix, S Qin, P Merle, A Granito, YH Huang, G Bodoky, M Pracht, ...
The Lancet 389 (10064), 56-66, 2017
15022017
EASL clinical practice guidelines: management of hepatocellular carcinoma
European Association For The Study Of The Liver
Journal of hepatology 69 (1), 182-236, 2018
14872018
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
V Mazzaferro, JM Llovet, R Miceli, S Bhoori, M Schiavo, L Mariani, ...
The lancet oncology 10 (1), 35-43, 2009
14852009
Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model
X Forns, S Ampurdanes, JM Llovet, J Aponte, L Quint, E Martınez-Bauer, ...
Hepatology 36 (4), 986-992, 2002
13132002
Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling
SM Wilhelm, L Adnane, P Newell, A Villanueva, JM Llovet, M Lynch
Molecular cancer therapeutics 7 (10), 3129-3140, 2008
13112008
Prognostic prediction and treatment strategy in hepatocellular carcinoma
J Bruix, JM Llovet
Hepatology 35 (3), 519-524, 2002
12732002
Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials
JM Llovet, J Bustamante, A Castells, R Vilana, MDC Ayuso, M Sala, C Br, ...
Hepatology 29 (1), 62-67, 1999
12251999
Gene expression in fixed tissues and outcome in hepatocellular carcinoma
Y Hoshida, A Villanueva, M Kobayashi, J Peix, DY Chiang, A Camargo, ...
New England Journal of Medicine 359 (19), 1995-2004, 2008
11192008
Novel advancements in the management of hepatocellular carcinoma in 2008
JM Llovet, J Bruix
Journal of hepatology 48, S20-S37, 2008
10962008
Molecular targeted therapies in hepatocellular carcinoma
JM Llovet, J Bruix
Hepatology 48 (4), 1312-1327, 2008
10882008
Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma
A Forner, R Vilana, C Ayuso, L Bianchi, M Sol, JR Ayuso, L Boix, M Sala, ...
Hepatology 47 (1), 97-104, 2008
9712008
Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics
M Varela, MI Real, M Burrel, A Forner, M Sala, M Brunet, C Ayuso, ...
Journal of hepatology 46 (3), 474-481, 2007
9712007
Il sistema al momento non pu eseguire l'operazione. Riprova pi tardi.
Articoli 1–20